Child Health

Risk of neural tube defects slightly higher for babies of women on HIV therapy containing dolutegravir

Children born to women on HIV therapy containing the drug dolutegravir since conception have a slightly higher risk of neural tube defects, compared to children born to women on regimens of other antiretroviral drugs.